Studies on the Role of Dopamine D1 Receptors in the Development and Expression of MDMA-induced Behavioral Sensitization in Rats

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2004 Sep 1

PMID 15338099

Citations 12

Authors

Maria Ramos

Beatriz Goni-Allo

Norberto Aguirre

Affiliations

Soon will be listed here.

Abstract

Rationale: There is a large body of evidence indicating that the mesoaccumbens dopamine pathway is critically involved in the expression of behavioral sensitization to amphetamine and cocaine, but its role in the development of sensitization to psychostimulants is not that sound. Very few studies, however, have examined the role of dopamine transmission in 3,4-methylenedioxymethamphetamine (MDMA)-induced sensitization.

Objectives: The effects of the D1 receptor antagonist SCH 23390 on the development and expression of MDMA-induced behavioral sensitization were investigated in rats.

Methods: During the development phase of sensitization, SCH 23390 was administered 15 min before every administration of MDMA. After 12 days of withdrawal, a MDMA challenge dose was given and locomotor activity was measured. In separate experiments, 15 min before the challenge injection of MDMA, SCH 23390 was administered either systemically or directly into the core of the nucleus accumbens (NAc) of MDMA-pretreated rats.

Results: SCH 23390 did not prevent the development of MDMA-induced behavioral sensitization but completely blocked the expression when given before the challenge dose of MDMA. The same results were obtained when SCH 23390 was locally applied into the core of the NAc.

Conclusions: The present data suggest that D1 receptor stimulation is not critical for the development of long-term MDMA sensitization, in agreement with what has been reported for cocaine. By contrast, expression of sensitization depends on the activation of D1 receptors located in the NAc core.

Citing Articles

Ameliorating effects of Acanthopanax koreanum extract and components on nicotine dependence and withdrawal symptoms.

Lee H, Ortiz D, Sayson L, Kim M, Cheong J, Kim H Addict Biol. 2024; 29(2):e13360.

PMID: 38380695 PMC: 10898842. DOI: 10.1111/adb.13360.

Effects of β-Phenylethylamine on Psychomotor, Rewarding, and Reinforcing Behaviors and Affective State: The Role of Dopamine D1 Receptors.

Ryu I, Kim O, Kim J, Sohn S, Choe E, Lim R Int J Mol Sci. 2021; 22(17).

PMID: 34502393 PMC: 8430604. DOI: 10.3390/ijms22179485.

Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels.

Ur Rehman N, Abbas M, Al-Rashida M, Tokhi A, Arshid M, Khan M Drug Des Devel Ther. 2020; 14:3777-3786.

PMID: 32982182 PMC: 7505708. DOI: 10.2147/DDDT.S270025.

Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D receptor mechanisms.

van de Wetering R, Schenk S Psychopharmacology (Berl). 2017; 234(7):1155-1164.

PMID: 28188355 DOI: 10.1007/s00213-017-4554-4.

Repeated exposure to MDMA triggers long-term plasticity of noradrenergic and serotonergic neurons.

Lanteri C, Doucet E, Hernandez Vallejo S, Godeheu G, Bobadilla A, Salomon L Mol Psychiatry. 2013; 19(7):823-33.

PMID: 23958955 DOI: 10.1038/mp.2013.97.

References

Beardsley P, Balster R, Harris L . Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend. 1986; 18(2):149-57. DOI: 10.1016/0376-8716(86)90047-5. View

Heidbreder C, Thompson A, Shippenberg T . Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther. 1996; 278(2):490-502. View

Stewart J, Vezina P . Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 1989; 495(2):401-6. DOI: 10.1016/0006-8993(89)90236-9. View

Li Y, Hu X, Berney T, Vartanian A, Stine C, Wolf M . Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse. 1999; 34(3):169-80. DOI: 10.1002/(SICI)1098-2396(19991201)34:3<169::AID-SYN1>3.0.CO;2-C. View

Kalivas P, Duffy P . Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci. 1993; 13(1):266-75. PMC: 6576317. View

GOLD L, Hubner C, Koob G . A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. Psychopharmacology (Berl). 1989; 99(1):40-7. DOI: 10.1007/BF00634450. View

Pierce R, Reeder D, Hicks J, MORGAN Z, Kalivas P . Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience. 1998; 82(4):1103-14. DOI: 10.1016/s0306-4522(97)00366-7. View

Tella S . Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol Biochem Behav. 1994; 48(1):151-9. DOI: 10.1016/0091-3057(94)90511-8. View

Vanderschuren L, Schoffelmeer A, Mulder A, de Vries T . Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology (Berl). 1999; 143(3):244-53. DOI: 10.1007/s002130050943. View

10.

Prasad B, Hochstatter T, Sorg B . Expression of cocaine sensitization: regulation by the medial prefrontal cortex. Neuroscience. 1999; 88(3):765-74. DOI: 10.1016/s0306-4522(98)00183-3. View

11.

White F, Kalivas P . Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 1998; 51(1-2):141-53. DOI: 10.1016/s0376-8716(98)00072-6. View

12.

White S, Obradovic T, Imel K, Wheaton M . The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol. 1996; 49(5):455-79. DOI: 10.1016/0301-0082(96)00027-5. View

13.

Paulson P, Robinson T . Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse. 1995; 19(1):56-65. PMC: 1859849. DOI: 10.1002/syn.890190108. View

14.

Morgan A, Horan B, Dewey S, Ashby Jr C . Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study. Eur J Pharmacol. 1997; 331(1):R1-3. DOI: 10.1016/s0014-2999(97)01035-2. View

15.

Spanos L, Yamamoto B . Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav. 1989; 32(4):835-40. DOI: 10.1016/0091-3057(89)90044-0. View

16.

Vezina P, Stewart J . The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 1989; 499(1):108-20. DOI: 10.1016/0006-8993(89)91140-2. View

17.

Levy A, Kim J, Ellison G . Chronic amphetamine alters D-2 but not D-1 agonist-induced behavioral responses in rats. Life Sci. 1988; 43(15):1207-13. DOI: 10.1016/0024-3205(88)90210-x. View

18.

White F, Joshi A, Koeltzow T, Hu X . Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology. 1997; 18(1):26-40. DOI: 10.1016/S0893-133X(97)00093-6. View

19.

Wolf M, Jeziorski M . Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 1993; 613(2):291-4. DOI: 10.1016/0006-8993(93)90913-8. View

20.

GOLD L, Koob G . MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology (Berl). 1989; 99(3):352-6. DOI: 10.1007/BF00445556. View